CD86 and neoplasm: Within the tumour specimens, the shIL37 group exhibited an increase in CD86 expression (Figure 6G,J) and a decrease in CD206 expression (Figure 6H,K), along with a lower percentage of Ki67‐positive cells (Figure 6F,I), when compared with the control and mock groups.